#ASH23 exhibition hall (Max Gelman for Endpoints News)
December 12, 2023 04:56 AM ESTUpdated 09:38 AM
R&D
Cell/Gene Tx

Biotech CAR-T roundup: Au­to­lus, Gra­cell tout ear­ly-stage da­ta at #ASH23

Max Gelman

Senior Editor

SAN DIEGO — Big Phar­ma com­pa­nies aren’t the on­ly play­ers at #ASH23. Many biotechs — in­clud­ing Au­to­lus and Gra­cell — who are look­ing to make their mark in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

J&J part­ners on STAT6; As­traZeneca, Dai­ichi with­draw lung can­cer drug EMA app

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

A service from the Financial Times